Olga N. Gaikova

Olga N. Gaikova

Auto-generated profile, based on publicly available information

Olga N. Gaikova

Golikov Research Center of Toxicology

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2024 in Extreme Medicine
Verified
Journal Article
Open access
PDF file
AMA. S. Melekhova
A. S. Melekhova
ABA. V. Belskaya
A. V. Belskaya
VZV. N. Zorina
V. N. Zorina
МММ. В. Мельникова
М. В. Мельникова
LKL. G. Kubarskaya
L. G. Kubarskaya
OGO. N. Gaikova
O. N. Gaikova
Introduction. Carbamates are widely used in the pharmaceutical industry, agriculture, and household chemicals. Being reversible cholinesterase inhibitors, carbamates can cause the development of generalized convulsive syndrome. Untimely treatment contributes to the emergence of persistent neurological disorders. In order to develop and adequately assess in preclinical studies the specific activity of new drugs for the relief of convulsive syndrome in acute intoxication with this group of substances, an easily reproducible experimental model of convulsive carbamate-induced syndrome is required.Objective. Development of an experimental model of generalized convulsive syndrome in rats using phenylcarbamate as a model toxicant for testing in preclinical studies of therapies for poisoning with cholinesterase inhibitors.Materials and methods. The study was performed using mongrel sexually mature male rats, aged 3 months (80 animals), divided into 4 groups (3 experimental and 1 control). At the first stage, the parameters of convulsive syndrome caused by model toxicants were compared: phenylcarbamate 1 mg/kg bw, corazol 65 mg/kg bw, and thiosemicarbazide 8 mg/kg bw. The following parameters were studied: motor activity (open field test), neuromotor functions (grip strength test), cognitive functions (conditioned avoidance responses, CAR), and cardiovascular indicators (ECG and cardiac rhythmogram assessment). The severity of the convulsive syndrome was identified by Racine stages. Additionally, the structure of brain tissues was evaluated by histological methods. second stage, biochemical parameters were studied in three experimental (with toxicants) and control groups. Some biochemical parameters were studied in the blood serum, assessing the function of the liver, kidneys, prooxidant and antioxidant systems. At the third stage, the activity of cholinesterase in the blood and brain was studied in 30 control and 30 experimental rats after phenylcarbamate exposure. Statistical processing of the results was carried out using Statistica v.10.Results. When modeling convulsive syndrome in rats, phenylcarbamate is comparable to corazol in terms of the onset of the latency period, duration and intensity of seizures. When implementing the model, a significant decrease in heart rate was recorded 48 h after administration. The CAR test found that the introduced substance increases the time of the first entry into the dark compartment before training. Significant changes in markers of liver function (ALT, bilirubin, cholesterol, triglycerides), lipid peroxidation and the antioxidant system (MDA, GPx) confirm the complexity of mechanisms responsible for the development of seizures and neurological disorders. The results of histological examination of brain tissues indicate that phenylcarbamate induces pronounced disorders of the brain structure in an experiment on rats.Conclusions. The developed experimental model of phenylcarbamate-based convulsive syndrome in rats is easy to reproduce, thus being recommended for preclinical studies of new drugs for the relief of convulsive syndrome in poisoning with cholinesterase inhibitors.

31 October 2024 in Extreme Medicine
Verified
Journal Article
Open access
PDF file
ANA. M. Nosov
A. M. Nosov
ABA. A. Bondarenko
A. A. Bondarenko
GKG. G. Katretskaya
G. G. Katretskaya
KGK. P. Golovko
K. P. Golovko
ASA. V. Shultz
A. V. Shultz
OGO. N. Gaikova
O. N. Gaikova
Introduction. Hemostasis of ongoing bleeding during cavitary surgical interventions is an urgent problem both in civil and military healthcare. The development of new effective and affordable agents for hemostasis of internal bleeding and their introduction into clinical practice may contribute to increasing the survival of injured patients.Objective. Study of general and local toxic effects of a local hemostatic agent (LHA) for intracavitary application.Materials and methods. The study was performed on 20 mongrel rats (10 males and 10 females) weighing 180–220 g. The experimental group of animals was implanted with the LHA into the abdominal cavity at a dose of 512 mg/kg body weight (bw). The animals of the control group underwent surgery without LHA implantation. Data analysis was performed using the Microsoft Excel 2013 and Statistica 10.0 software applications.Results. The health status, body weight, food and water consumption, and mass coefficients of internal organs in the experimental animals did not differ from those in the control group. The hematological and biochemical blood parameters showed values within the reference norm. The macro- and microscopic examination of the internal organs revealed a local irritant effect of the agent under study.Conclusion. The laboratory animals tolerated the intraperitoneal implantation of the tested local hemostatic agent at a dose of 512 mg/kg bw well. A further study of its toxic properties and effectiveness is validated.

15 January 2026 in Toxicological Review
Verified
Journal Article
Closed access
ABAlisa V. Belskaya
Alisa V. Belskaya
VZVeronika N. Zorina
Veronika N. Zorina
AMAlexandra S. Melekhova
Alexandra S. Melekhova
ABAlexandr Ya. Bespalov
Alexandr Ya. Bespalov
MMMargarita V. Melnikova
Margarita V. Melnikova
OGOlga N. Gaikova
Olga N. Gaikova
Introduction. Reversible cholinesterase inhibitors include compounds with different structures and effects on the body, which requires additional research.The aim of the work is a comparative study of the manifestations of convulsive syndrome in an experiment on animals, using various cholinesterase inhibitors as model toxicants.Material and methods. A comparative study of the manifestations of convulsive syndrome was conducted with a single intraperitoneal administration of Phenylcarbamate, 1 mg/kg, Galantamine, 25 mg/kg, and Tacrine, 15 mg/kg to rats.Results. Differences in the latent period of onset and duration of seizure syndrome between all groups were revealed. Statistically significant differences in the parameters of motor activity, neuromotor and cognitive functions were not established. According to the results of histological examination after exposure to Phenylcarbamate, Tacrine and Galantamine, individual deviations from the norm were recorded in the hippocampus and cerebral cortex: pronounced expansion of perivascular and pericellular spaces, the appearance of dark and wrinkled neurons.Limitations. The number of animals used in the study was in accordance with bioethical principles and the requirement for a sufficient number of animals for statistically reliable results: 10 animals in each group.Conclusion. It has been established that reversible cholinesterase inhibitors can vary significantly in the severity and pathogenetic features of their effects on the body, which must be taken into account when developing treatments for convulsive syndrome.Compliance with ethical standards. The experiment with animals was performed after a positive conclusion of the bioethical commission of the S.N. Golikov Scientific and Clinical Center of Toxicology (conclusion N 5/23, 20.12.2023).Authors' contribution: Belskaya A.V., Melekhova A.S., Melnikova M.V. – conducting scientific research (animal experiments), material processing, text writing; Bespalov A.Ya. – synthesis of model toxicants; Gaikova O.N. – conducting a histological examination; Zorina V.N. – scientific guidance in conducting research, text writing and editing. All co-authors – approval of the final version of the article, responsibility for the integrity of all parts of the article.Conflict of interests. The authors declare the absence of obvious and potential conflicts of interest in connection with the publication of this article.Funding. The study was conducted within the framework of the implementation of the research project code “Provodnik” under the State Project of S.N. Golikov Scientific and Clinical Center of Toxicology (No. 124022400179-8).Received: April 14, 2025 / Accepted: November 25, 2025 / Published: January 15, 2026

16 July 2026
Verified
Journal Article
Open access
PDF file
JIJu. Ju. Ivnitsky
Ju. Ju. Ivnitsky
MRM. А. Rozhko
M. А. Rozhko
OGO. N. Gajkova
O. N. Gajkova
LKL. G. Kubarskaya
L. G. Kubarskaya
AAA. R. Abdrakhmanova
A. R. Abdrakhmanova
VRV. L. Rejniuk
V. L. Rejniuk
Парадоксальность влияния фентанила на температуру тела, гемограмму и кровообращение крыс при перегревании